StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific biên lợi nhuận phân khúc (Segment Income Margin) — Laboratory Products & Biopharma Services (%)

IR Financial Reconciliation Package & SEC MD&A

QuarterlyAnnual
Latest, Q3 2026
15.5%
Period ended Sep 30, 2026
Change on a year earlier
+1.0 pts
14.5% in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiên lợi nhuận phân khúc (Segment Income Margin) — Laboratory Products & Biopharma Services (%)Year on yearSource
Q3 2026Sep 30, 202615.5%+1.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 202614.0%+0.2 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 202612.9%-0.1 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 202514.5%+0.5 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 202514.5%+1.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 202513.8%+0.9 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 202513.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 202414.0%0.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 202413.5%-2.9 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 202412.9%-1.2 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 202413.0%-0.8 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 202314.0%-0.1 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 202316.4%+3.4 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 202314.1%+1.6 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 202313.8%+2.4 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 202214.1%–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Biên lợi nhuận phân khúc (Segment Income Margin) — Laboratory Products & Biopharma Services (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_margin_lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.